Home
>
National Drug Code (NDC)
>
Etoposide
Etoposide - 0378-3266-94 - (etoposide)
Drug Information of Etoposide
| Product NDC: | 0378-3266 |
| Proprietary Name: | Etoposide |
| Non Proprietary Name: | etoposide |
| Active Ingredient(s): | 50 mg/1 & nbsp; etoposide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Etoposide
| Product NDC: | 0378-3266 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075635 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091123 |
Package Information of Etoposide
| Package NDC: | 0378-3266-94 |
| Package Description: | 20 CAPSULE in 1 CARTON (0378-3266-94) |
NDC Information of Etoposide
| NDC Code | 0378-3266-94 |
| Proprietary Name | Etoposide |
| Package Description | 20 CAPSULE in 1 CARTON (0378-3266-94) |
| Product NDC | 0378-3266 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etoposide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20091123 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ETOPOSIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
